Kala Bio KALA
NASDAQ KALA
$0.55 0.00 (-0.34%)
As of: Sep 10, 2026 · 1:22 PM EDT

Kala Bio (KALA) Total Liabilities (2016 - 2026)

Kala Bio's (KALA) quarterly Total Liabilities came in at $1.5 million in Q2 2026, down 96.08% year-over-year from $39.3 million in Q2 2025, and down 1.22% quarter-over-quarter from $1.6 million in Q1 2026.

Analysis

Kala Bio (KALA) Total Liabilities (2016 - 2026) Analysis & Trends

Kala Bio has disclosed Total Liabilities across 11 years of filings, most recently posting $1.5 million for Q2 2026.

  • In Q2 2026, Total Liabilities fell 96.08% year-over-year to $1.5 million; the TTM figure through Jun 2026 stood at $1.5 million (down 96.08% YoY), while the FY2025 annual figure was $2.5 million, down 94.22% from the prior year.
  • Total Liabilities came in at $1.5 million for Q2 2026 at Kala Bio, down from $1.6 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $116.9 million in Q1 2022 to a low of $1.5 million in Q2 2026.
  • Average Total Liabilities over 5 years is $49.4 million, with a median of $47.6 million recorded in 2024.
  • Year-over-year, Total Liabilities retreated 2.28% in 2024 and slumped 96.34% in 2026.
  • Over 5 years, Total Liabilities stood at $67.8 million in 2022, then dropped by 28.6% to $48.4 million in 2023, then decreased by 10.93% to $43.2 million in 2024, then slumped by 94.22% to $2.5 million in 2025, then plunged by 38.33% to $1.5 million in 2026.
  • Per Business Quant data, the three most recent Total Liabilities figures were $1.5 million in Q2 2026, $1.6 million in Q1 2026, and $2.5 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Amgen 206.70 Bn 192.71 Bn 7.24 Bn 83.95 Bn
2 Gilead Sciences 180.18 Bn 177.00 Bn 6.22 Bn 37.53 Bn
3 Vertex Pharmaceuticals 131.45 Bn 123.60 Bn 2.84 Bn 7.18 Bn
4 Regeneron Pharmaceuticals 81.94 Bn 73.95 Bn 3.93 Bn 10.02 Bn
5 Argenx Se 60.60 Bn 55.42 Bn 1.37 Bn 1.62 Bn
6 Moderna 53.81 Bn 48.67 Bn 52.00 Mn 4.20 Bn
7 Alnylam Pharmaceuticals 33.46 Bn 30.15 Bn 992.69 Mn 4.20 Bn
8 Biogen 31.82 Bn 30.54 Bn 1.96 Bn 13.24 Bn
9 Roivant Sciences 29.10 Bn 29.10 Bn 1.16 Mn 384.62 Mn
10 Kala Bio 8.48 Mn 8.48 Mn - 1.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.54 Mn
Mar 31, 2026 1.56 Mn
Dec 31, 2025 2.49 Mn
Sep 30, 2025 33.69 Mn
Jun 30, 2025 39.26 Mn
Mar 31, 2025 42.54 Mn
Dec 31, 2024 43.15 Mn
Sep 30, 2024 47.22 Mn
Jun 30, 2024 47.89 Mn
Mar 31, 2024 46.37 Mn
Dec 31, 2023 48.45 Mn
Sep 30, 2023 49.90 Mn
Jun 30, 2023 49.01 Mn
Mar 31, 2023 48.77 Mn
Dec 31, 2022 67.85 Mn
Sep 30, 2022 86.67 Mn
Jun 30, 2022 116.53 Mn
Mar 31, 2022 116.86 Mn
Dec 31, 2021 122.62 Mn
Sep 30, 2021 132.35 Mn